IE
AEGR

Israel Englander’s Aegerion Pharmaceuticals AEGR Stock Holding History

Israel Englander’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-52,500
Closed -$3.73M – 4144
2013
Q4 		$3.73M Buy
+52,500
New +$4.01M 0.01% 1386

Israel Englander's AEGR Position: Q4 2016 in Review

Israel Englander sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 165,879 shares — an estimated $493K sold.

Israel Englander first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $32M in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Israel Englander reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Israel Englander sold 165,879 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $493K.
  • Israel Englander first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Israel Englander's Aegerion Pharmaceuticals position peaked at $32M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.